Notably, high expression levels of HDAC4 and TRIM27 were identified as favorable prognostic factors for bladder cancer patients, while elevated expression of EGR2 and UBE2I was associated with an unfavorable prognosis (Figure 1C-F). Here, UBE2I is linked to urinary bladder carcinoma.